SG162614A1 - Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors - Google Patents

Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors

Info

Publication number
SG162614A1
SG162614A1 SG200607462-9A SG2006074629A SG162614A1 SG 162614 A1 SG162614 A1 SG 162614A1 SG 2006074629 A SG2006074629 A SG 2006074629A SG 162614 A1 SG162614 A1 SG 162614A1
Authority
SG
Singapore
Prior art keywords
penems
alkylidene
bicyclic
beta
lactamases inhibitors
Prior art date
Application number
SG200607462-9A
Other languages
English (en)
Inventor
Aranapakam Mudumbai Venkatesan
Tarek Suhayl Mansour
Takao Abe
Itsuki Yamamura
Tsuyoshi Takasaki
Atul Agarwal
Osvaldo Dos Santos
Sum Fuk-Wah
Lin Yang-I
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of SG162614A1 publication Critical patent/SG162614A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/881—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hydrogen atom or an unsubstituted hydrocarbon radical, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/861—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hydrocarbon radical or a substituted hydrocarbon radical, directly attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG200607462-9A 2002-05-01 2003-04-30 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors SG162614A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37705202P 2002-05-01 2002-05-01

Publications (1)

Publication Number Publication Date
SG162614A1 true SG162614A1 (en) 2010-07-29

Family

ID=29401437

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200607462-9A SG162614A1 (en) 2002-05-01 2003-04-30 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors

Country Status (21)

Country Link
US (3) US7112582B2 (enExample)
EP (2) EP1988093A1 (enExample)
JP (2) JP4602759B2 (enExample)
KR (1) KR20050007368A (enExample)
CN (2) CN1649883B (enExample)
AR (1) AR039774A1 (enExample)
AU (1) AU2003231205A1 (enExample)
BR (1) BR0309757A (enExample)
CA (1) CA2483538A1 (enExample)
CR (3) CR7508A (enExample)
EC (1) ECSP045397A (enExample)
IL (1) IL164899A0 (enExample)
MX (1) MXPA04010663A (enExample)
NO (1) NO20044549L (enExample)
NZ (1) NZ536182A (enExample)
RU (1) RU2339640C2 (enExample)
SG (1) SG162614A1 (enExample)
TW (1) TW200307687A (enExample)
UA (1) UA79117C2 (enExample)
WO (1) WO2003093279A1 (enExample)
ZA (1) ZA200409686B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
EP1660506A4 (en) * 2003-08-25 2009-02-25 Revaax Pharmaceuticals Llc ORAL NEUROTHERAPEUTIC CEFAZOLINE COMPOSITIONS
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
TW200716104A (en) * 2005-06-01 2007-05-01 Wyeth Corp Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
AU2006285308A1 (en) * 2005-07-27 2007-03-08 Wyeth Tricyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic
RU2008102912A (ru) * 2005-07-27 2009-09-10 Вайет (Us) Сочетание ингибиторов бетта-лактазмы бициклического 6-алкилиденпенема с бетта-лактанным антибиотиком: антибиотик широкого спектра
GT200600380A (es) * 2005-08-24 2007-03-29 Proceso para la preparacion de inhibidores de beta-lactamasa
US20090018332A1 (en) * 2007-06-28 2009-01-15 Wyeth Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
CN104119858A (zh) * 2013-04-27 2014-10-29 海洋王照明科技股份有限公司 一种铱金属配合物有机电致磷光材料及其制备方法和有机电致发光器件
CN104119857A (zh) * 2013-04-27 2014-10-29 海洋王照明科技股份有限公司 一种铱金属配合物有机电致磷光材料及其制备方法和有机电致发光器件
BR112018015191B1 (pt) 2016-02-23 2023-10-17 Pfizer Inc Compostos de 6,7-di-hidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxamida, seu uso e composição farmacêutica que os compreende
CN108473510B (zh) * 2016-04-28 2021-10-29 豪夫迈·罗氏有限公司 制备2-吡唑并[1,5-a]吡嗪-2-基吡啶并[1,2-a]嘧啶-4-酮的方法
RU2019107162A (ru) 2016-08-15 2020-09-15 Байер Кропсайенс Акциенгезельшафт Конденсированные бициклические гетероциклические производные в качестве средств для борьбы с вредителями
CN114957258A (zh) * 2021-02-25 2022-08-30 华东理工大学 基于碳青霉烯结构的广谱丝氨酸β-内酰胺酶抑制剂的合成及其在耐药细菌抑制中的应用
BR112023023866A2 (pt) * 2021-05-21 2024-02-06 Chengdu Baiyu Pharmaceutical Co Ltd Derivado de piperazina e seu uso na medicina

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000525A1 (en) * 1985-07-22 1987-01-29 Beecham Group P.L.C. 6-alkylidene penems
WO1994010178A1 (en) * 1992-10-29 1994-05-11 Smithkline Beecham P L C 6-(substituted methylene) penems and intermediates
WO1995017184A1 (en) * 1993-12-23 1995-06-29 Smithkline Beecham Plc Pharmaceutical compositions containing ceftriaxone and penems
US5911985A (en) * 1994-04-25 1999-06-15 Smithkline Beecham P.L.C. Pharmaceutical formulations containing a β-lactamase inhibiting penem in combination with β-lactam antibiotic and their use in the treatment of bacterial infections

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2004A (en) * 1841-03-12 Improvement in the manner of constructing and propelling steam-vessels
US4206067A (en) * 1978-10-02 1980-06-03 Chevron Research Company Thermally stabilized erosion-inhibited functional fluids containing perhalometal compounds and an organic base
DE3176517D1 (en) 1980-04-24 1987-12-17 Beecham Group Plc Beta-lactam compounds, their preparation and use
EP0120613A1 (en) 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
GB8402086D0 (en) 1984-01-26 1984-02-29 Beecham Group Plc Compounds
FI82471C (fi) 1984-01-26 1991-03-11 Beecham Group Plc Foerfarande foer framstaellning av farmakologiskt aktiva 6-metylenpenemderivater.
EP0150984B1 (en) 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
EP0167050A1 (en) * 1984-06-21 1986-01-08 Beecham Group Plc Clavulanate compounds, their preparation and use and intermediates thereof
GB8518422D0 (en) 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB8518421D0 (en) 1985-07-22 1985-08-29 Beecham Group Plc Compounds
ATE159021T1 (de) 1986-01-17 1997-10-15 Beecham Group Plc Verfahren zur herstellung von penem derivaten und zwischenprodukte zu dieser herstellung
US4891369A (en) * 1986-12-03 1990-01-02 Taiho Pharmaceutical Company, Limited 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren
GB8724566D0 (en) 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
GB8729614D0 (en) 1987-12-18 1988-02-03 Beecham Group Plc Novel compounds
GB8729613D0 (en) 1987-12-18 1988-02-03 Beecham Group Plc Novel compounds
NZ237202A (en) 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
EP0447704A1 (en) 1990-03-21 1991-09-25 Smithkline Beecham Farmaceutici S.p.A. N-Acylated azacyclic compounds, processes for their preparations and their use as medications
GB9116236D0 (en) 1991-07-27 1991-09-11 Smithkline Beecham Plc Novel compounds
US5349045A (en) 1993-01-26 1994-09-20 United States Surgical Corporation Polymer derived from cyclic amide and medical devices manufactured therefrom
US5629322A (en) 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase
OA11666A (en) * 1998-10-15 2004-12-08 Sarawak Medichem Pharmaceuticals Inc Method and composition for treating and preventingtuberculosis.
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
EP1199077A1 (en) * 2000-10-19 2002-04-24 Amura Limited Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
GB0106428D0 (en) * 2001-03-15 2001-05-02 Amura Ltd Antibacterial composition
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos
TW200716104A (en) * 2005-06-01 2007-05-01 Wyeth Corp Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
RU2008102912A (ru) * 2005-07-27 2009-09-10 Вайет (Us) Сочетание ингибиторов бетта-лактазмы бициклического 6-алкилиденпенема с бетта-лактанным антибиотиком: антибиотик широкого спектра

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000525A1 (en) * 1985-07-22 1987-01-29 Beecham Group P.L.C. 6-alkylidene penems
WO1994010178A1 (en) * 1992-10-29 1994-05-11 Smithkline Beecham P L C 6-(substituted methylene) penems and intermediates
WO1995017184A1 (en) * 1993-12-23 1995-06-29 Smithkline Beecham Plc Pharmaceutical compositions containing ceftriaxone and penems
US5911985A (en) * 1994-04-25 1999-06-15 Smithkline Beecham P.L.C. Pharmaceutical formulations containing a β-lactamase inhibiting penem in combination with β-lactam antibiotic and their use in the treatment of bacterial infections

Also Published As

Publication number Publication date
EP1499621A1 (en) 2005-01-26
CR10986A (es) 2009-09-09
US7112582B2 (en) 2006-09-26
NZ536182A (en) 2006-10-27
EP1988093A1 (en) 2008-11-05
JP4602759B2 (ja) 2010-12-22
AR039774A1 (es) 2005-03-02
US20060217361A1 (en) 2006-09-28
RU2004135082A (ru) 2006-01-20
KR20050007368A (ko) 2005-01-17
TW200307687A (en) 2003-12-16
NO20044549L (no) 2005-01-25
UA79117C2 (en) 2007-05-25
CN101570545A (zh) 2009-11-04
CR7508A (es) 2005-01-05
JP2010215652A (ja) 2010-09-30
RU2339640C2 (ru) 2008-11-27
CR10983A (es) 2009-09-09
US20040077622A1 (en) 2004-04-22
WO2003093279A1 (en) 2003-11-13
US7812014B2 (en) 2010-10-12
CN1649883A (zh) 2005-08-03
CA2483538A1 (en) 2003-11-13
AU2003231205A1 (en) 2003-11-17
JP2005533017A (ja) 2005-11-04
US20080312203A1 (en) 2008-12-18
BR0309757A (pt) 2005-03-08
ECSP045397A (es) 2005-01-03
ZA200409686B (en) 2007-09-26
CN1649883B (zh) 2010-05-26
MXPA04010663A (es) 2005-04-20
IL164899A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
SE0102315D0 (sv) Compounds
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
TW200508214A (en) Novel compounds
GB0226930D0 (en) Chemical compounds
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
GB0112348D0 (en) Compounds
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MY144318A (en) Methods of treating hiv infection.
MXPA03010761A (es) Combinaciones farmaceuticas.
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
MXPA04005809A (es) Inhibidores de proteinas quinasas.
PL377176A1 (pl) N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
TW200727897A (en) Bicyclic 6-alkylidene-penem β-lactamase inhibitors and β-lactam antibiotic combination: a broad spectrum antibiotic